Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,837,289
  • Shares Outstanding, K 22,469
  • Annual Sales, $ 614,380 K
  • Annual Income, $ -18,520 K
  • EBIT $ 163 M
  • EBITDA $ 245 M
  • 60-Month Beta 0.48
  • Price/Sales 3.03
  • Price/Cash Flow 10.89
  • Price/Book 3.68

Options Overview Details

View History
  • Implied Volatility 40.67% (-2.94%)
  • Historical Volatility 25.41%
  • IV Percentile 34%
  • IV Rank 27.27%
  • IV High 73.85% on 07/24/25
  • IV Low 28.23% on 01/17/25
  • Expected Move (DTE 11) 7.00 (8.56%)
  • Put/Call Vol Ratio 2.00
  • Today's Volume 3
  • Volume Avg (30-Day) 171
  • Put/Call OI Ratio 7.03
  • Today's Open Interest 3,704
  • Open Int (30-Day) 2,085
  • Expected Range 74.77 to 88.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.63
  • Number of Estimates 6
  • High Estimate 1.71
  • Low Estimate 1.53
  • Prior Year 1.35
  • Growth Rate Est. (year over year) +20.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.99 +4.85%
on 11/21/25
95.45 -14.33%
on 11/07/25
-10.85 (-11.71%)
since 11/05/25
3-Month
77.99 +4.85%
on 11/21/25
99.50 -17.82%
on 09/10/25
-13.58 (-14.24%)
since 09/05/25
52-Week
52.50 +55.75%
on 12/19/24
99.50 -17.82%
on 09/10/25
+25.78 (+46.04%)
since 12/05/24

Most Recent Stories

More News
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise

PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has established The FutureVision Advisory Council...

ANIP : 81.77 (-1.17%)
ANI Pharmaceuticals Announces Board Transition

Patrick D. Walsh steps down as Chairman and will complete his current term as Board member Thomas J. Haughey has been unanimously elected to serve as the next Chairman of the Board PRINCETON, N.J.,...

ANIP : 81.77 (-1.17%)
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference

PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside...

ANIP : 81.77 (-1.17%)
1 Russell 2000 Stock to Consider Right Now and 2 We Avoid

1 Russell 2000 Stock to Consider Right Now and 2 We Avoid

CRAI : 189.31 (+0.79%)
ANIP : 81.77 (-1.17%)
TRUP : 36.93 (-0.27%)
The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q3 Earnings Call

ANIP : 81.77 (-1.17%)
Generic Pharmaceuticals Stocks Q3 Recap: Benchmarking ANI Pharmaceuticals (NASDAQ:ANIP)

Generic Pharmaceuticals Stocks Q3 Recap: Benchmarking ANI Pharmaceuticals (NASDAQ:ANIP)

ANIP : 81.77 (-1.17%)
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London

PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside...

ANIP : 81.77 (-1.17%)
ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook

ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook

ANIP : 81.77 (-1.17%)
ANI: Q3 Earnings Snapshot

ANI: Q3 Earnings Snapshot

ANIP : 81.77 (-1.17%)
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Strong Q3 Numbers, Stock Soars

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Strong Q3 Numbers, Stock Soars

ANIP : 81.77 (-1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 85.65
2nd Resistance Point 84.39
1st Resistance Point 83.08
Last Price 81.77
1st Support Level 80.51
2nd Support Level 79.26
3rd Support Level 77.95

See More

52-Week High 99.50
Last Price 81.77
Fibonacci 61.8% 81.55
Fibonacci 50% 76.00
Fibonacci 38.2% 70.45
52-Week Low 52.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar